3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
3
Sturge-Weber Syndrome
2
Neoplasms
2
Nausea
2
Marijuana Abuse
2
Colonic Neoplasms
2
Anxiety Disorders
2
Vomiting
1
Solid Tumor
1
Parasomnias
1
Pain
1
Glioblastoma
1
Dysgeusia
1
Drug Resistant Epilepsy
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Chemotherapy-Induced Peripheral Neuropathy
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Hepatocellular
1
Cachexia
1
Breast Carcinoma In Situ
1
Breast Cancer Female
1
Arthralgia
1
Appetitive Behavior
1
Interventions
Surveys and Questionnaires
15
Acupuncture Therapy
15
Fentanyl
14
Morphine
13
Acetaminophen
13
Analgesia
12
Lidocaine
11
Ketamine
11
Bupivacaine
11
Methadone
10
Therapeutics
9
Ropivacaine
9
Psychiatric Rehabilitation
9
Oxycodone
9
Hydromorphone
7
Saline Solution
6
Radiotherapy
6
Music Therapy
6
Early Intervention, Educational
6
Zoledronic Acid
5
Yoga
5
Water
5
Methods
5
Control Groups
5
Transcutaneous Electric Nerve Stimulation
4
Therapeutic Touch
4
Physical Therapy Modalities
4
Massage
4
Ketorolac
4
Exercise
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pain
×
Cannabidiol
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled